Literature DB >> 6861998

Synthesis, acute toxicity and chemotherapeutic anti-cancer activities of a new tripeptidic mustard.

A De Barbieri, L Dall'Asta, A Comini, V Springolo, P Mosconi, G Coppi.   

Abstract

A new antitumor agent having the chemical composition of 3-(p-fluorophenyl)-Lalanyl-3-[m-bis-(2-chloroethyl)aminophenyl]-L- alanyl-L-methionine ethyl ester hydrochloride (PTT 119) was synthetized. It fundamental toxicological data in mice and rats were assessed; its antitumor activity was investigated by establishing in mice, inoculated with L 1210 leukemia or in AKR mice with spontaneous leukemia of viral origin, a significant increase in Mean Survival Time as well as a percent increase of Increased Life Span and of the number of survivors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861998

Source DB:  PubMed          Journal:  Farmaco Sci        ISSN: 0430-0920


  7 in total

1.  Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas.

Authors:  F Gherlinzoni; P Mazza; P L Zinzani; S Tura; F Lanza; G Castoldi; G Bellesi; P L Rossi Ferrini; L Mangoni; V Rizzoli
Journal:  Blut       Date:  1990-03

2.  Phase I study of beta-alanyl-melphalan as a potent anticancer drug.

Authors:  B L Tsay; L Wolfinbarger
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.

Authors:  S Tura; P Mazza; F Gherlinzoni; P L Zinzani; G Poletti; G Visani; R M Lemoli; M Cavo; P Galieni; C Tassi
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119).

Authors:  F Verlicchi; S Boschi; G Visani; A Guidi; P Tosi; M Cavo; S Tura
Journal:  Blut       Date:  1990-11

5.  Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.

Authors:  M J Yagi; J G Bekesi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments.

Authors:  A Jeney; L Kopper; P Nagy; K Lapis; H Süli-Vargha; K Medzihradszky
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Pharmacokinetics of peptichemio in myeloma patients: release of m-L-sarcolysin in vivo and in vitro.

Authors:  H Ehrsson; R Lewensohn; I Wallin; M Hellström; G Merlini; B Johansson
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.